Arcutis Biotherapeutics
ARQT
ARQT
280 hedge funds and large institutions have $3.76B invested in Arcutis Biotherapeutics in 2025 Q4 according to their latest regulatory filings, with 73 funds opening new positions, 102 increasing their positions, 76 reducing their positions, and 25 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
18% more funds holding
Funds holding: 237 → 280 (+43)
1.27% more ownership
Funds ownership: 104.92% → 106.19% (+1.3%)
43% less funds holding in top 10
Funds holding in top 10: 7 → 4 (-3)
Holders
280
Holding in Top 10
4
Calls
$21.1M
Puts
$2.6M
Top Buyers
| 1 | +$38M | |
| 2 | +$37.5M | |
| 3 | +$27.6M | |
| 4 |
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Toronto,
Ontario, Canada
|
+$23M |
| 5 |
State Street
Boston,
Massachusetts
|
+$21.7M |
Top Sellers
| 1 | -$141M | |
| 2 | -$63.4M | |
| 3 | -$28.5M | |
| 4 |
PBPIA
Pivotal bioVenture Partners Investment Advisor
San Francisco,
California
|
-$19.3M |
| 5 |
Janus Henderson Group
London,
United Kingdom
|
-$14.5M |
